Neothetics, Inc Report issue

For profit Phase 2 Phase 3
Founded: San Diego CA United States (2007)
Status: Acquired by Evofem Inc. (2018)

Organization Overview

First Clinical Trial
2007
NCT00624416
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Lipothera

Active Ingredients

Drugs in Phase 3 Trials (1)

salmeterol (serevent) (13 trials)

Drugs in Phase 2 Trials (3)

fluticasone (cutivate) (6 trials)

isoprenaline (1 trial)

prednisone (meticorten) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Exophthalmos (Phase 2)

Eye Diseases (Phase 2)

Lipoma (Phase 2)

Obesity (Phase 2)

Thyroid Diseases (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 14
  • # of Trial APIs: 4